Stifel Financial
NTRP

Stifel Financial’s Neurotrope, Inc. Common NTRP Stock Holding History

Stifel Financial’s Portfolio NTRP Stock Details NTRP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-30,214
Closed -$108K – 2888
2018
Q4 		$108K Sell
30,214
-79,786
-73% -$483K ﹤0.01% 2557
2018
Q3 		$969K Hold
110,000
– – ﹤0.01% 1690
2018
Q2 		$1.06M Hold
110,000
– – ﹤0.01% 1571
2018
Q1 		$895K Hold
110,000
– – ﹤0.01% 1651
2017
Q4 		$774K Hold
110,000
– – ﹤0.01% 1670
2017
Q3 		$568K Hold
110,000
– – ﹤0.01% 1807
2017
Q2 		$1.03M Buy
110,000
+80,572
+274% +$861K ﹤0.01% 1457
2017
Q1 		$562K Buy
+29,428
New +$557K ﹤0.01% 1752

Other funds holding NTRP

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CC
Cannell & Co New York $3.15B AUM 30.62% 1-Year Est. Return
TCM
Tanaka Capital Management New York $59.9M AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
MA
MYDA Advisors Woodmere, New York $608M AUM 77.08% 1-Year Est. Return
OCMI
Oaktop Capital Management II Chatham, New Jersey $1.34B AUM 114.5% 1-Year Est. Return
NRS
Neville Rodie & Shaw New York $1.55B AUM 46.95% 1-Year Est. Return
JMPWA
JP Morgan Private Wealth Advisors San Francisco, California $35B AUM 24.26% 1-Year Est. Return
NP
NorthRock Partners Minneapolis, Minnesota $6.2B AUM 15.8% 1-Year Est. Return
Eagle Capital Management (New York)
Eagle Capital Management (New York) New York $29.8B AUM 12.13% 1-Year Est. Return

Stifel Financial's NTRP Position: Q1 2019 in Review

Stifel Financial sold out of Neurotrope, Inc. Common (NTRP) in Q1 2019, closing a stake of 30,214 shares — an estimated $108K sold.

Stifel Financial first reported a position in NTRP in Q1 2017 and held it in 8 quarters. The position peaked at $1.06M in Q2 2018. 32 funds tracked by Wall St. Rank hold NTRP as of Q1 2019.

  • Stifel Financial reported no remaining Neurotrope, Inc. Common position as of Q1 2019 after selling out during the quarter.
  • Stifel Financial sold 30,214 Neurotrope, Inc. Common shares in Q1 2019, an estimated $108K.
  • Stifel Financial first reported a position in Neurotrope, Inc. Common in Q1 2017 and held it in 8 quarters.
  • Stifel Financial's Neurotrope, Inc. Common position peaked at $1.06M in Q2 2018.
  • 32 funds tracked by Wall St. Rank held Neurotrope, Inc. Common as of Q1 2019.

Based on Stifel Financial's 13F filing for Q1 2019, filed 14 May 2019.